or Try an Advanced Search...

    Technical Analysis for AMRN - Amarin Corporation plc

    Grade Last Price % Change Price Change
    F 0.49 0.75% 0.00
    AMRN closed up 0.75 percent on Wednesday, November 20, 2024, on 1.62 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical AMRN trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish 0.75%
    Lower Bollinger Band Walk Weakness 0.75%
    Wide Bands Range Expansion 0.75%
    Lower Bollinger Band Touch Weakness 0.75%
    Oversold Stochastic Weakness 0.75%
    Older End-of-Day Signals for AMRN ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 18 hours ago
    60 Minute Opening Range Breakdown about 20 hours ago
    Down 2 % about 22 hours ago
    Lower Bollinger Band Support about 22 hours ago
    1.5x Volume Pace about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    AMRN Chart by TradingView
    Basic chart:

    Profile

    Amarin Corporation plc Description

    Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Acid Organic Compounds Cardiovascular Disease Therapeutic Products Lipid Vascular Disease Nutrition Cholesterol Lipoprotein Fatty Acids Low Density Lipoprotein Triglyceride Statin Therapy

    Is AMRN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
    Nov 19 Top 3 Health Care Stocks You'll Regret Missing In Q4
    Nov 11 Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual ...
    Nov 1 Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...
    Oct 31 Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
    Oct 31 Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript
    Oct 31 Amarin Corporation plc (AMRN) Q3 2024 Earnings Call Transcript
    Oct 30 Amarin Corporation plc 2024 Q3 - Results - Earnings Call Presentation
    Oct 30 Amarin: Q3 Earnings Snapshot
    Oct 30 Amarin Non-GAAP EPS of -$0.05 beats by $0.01, revenue of $42.3M misses by $2.21M
    See more AMRN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.37
    52 Week Low 0.4565
    Average Volume 972,966
    200-Day Moving Average 0.78
    50-Day Moving Average 0.58
    20-Day Moving Average 0.56
    10-Day Moving Average 0.53
    Average True Range 0.04
    RSI (14) 35.90
    ADX 18.13
    +DI 15.41
    -DI 28.03
    Chandelier Exit (Long, 3 ATRs) 0.56
    Chandelier Exit (Short, 3 ATRs) 0.56
    Upper Bollinger Bands 0.66
    Lower Bollinger Band 0.47
    Percent B (%b) 0.12
    BandWidth 32.55
    MACD Line -0.03
    MACD Signal Line -0.02
    MACD Histogram -0.0107
    Fundamentals Value
    Market Cap 201.86 Million
    Num Shares 408 Million
    EPS -0.12
    Price-to-Earnings (P/E) Ratio -4.12
    Price-to-Sales 1.54
    Price-to-Book 0.89
    PEG Ratio -1.74
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.53
    Resistance 3 (R3) 0.53 0.51 0.52
    Resistance 2 (R2) 0.51 0.50 0.51 0.52
    Resistance 1 (R1) 0.50 0.50 0.50 0.51 0.52
    Pivot Point 0.49 0.49 0.49 0.49 0.49
    Support 1 (S1) 0.48 0.48 0.47 0.48 0.47
    Support 2 (S2) 0.47 0.48 0.47 0.47
    Support 3 (S3) 0.46 0.47 0.47
    Support 4 (S4) 0.46